| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
3 companies
Springer Timothy A is a Director, 10% Owner at Cartesian Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $240.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2017 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 518 | $13.75 | $7,122.50 | +3.2% | |
| May 18, 2017 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 16,104 | $14.00 | $225,523.46 | +143.2% |